Delivery Order SPE2DB25D3202-SPE2DB25FTBDE
- Not listed
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,735.70 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a pediatric cardiovascular medication supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $8,835.12 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency awarded a $42,662.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a non-set-aside competitive award with a completion date of August 28, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $8,331.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price delivery order, with an ultimate completion date of August 7, 2025, represents a pediatric or maintenance supply requirement for this specialty cardiovascular medication used to treat high cholesterol. The contract was competitively awarded with no set-aside designation and will be performed...
- The Defense Logistics Agency awarded a $9,610.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $4,167.89 for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $4,540.44 with firm fixed pricing. This competitively awarded, non-set-aside delivery order is expected to be completed by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a routine pharmaceutical procurement under the company's larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBDEDelivery Order
The Defense Logistics Agency awarded a $1,562.13 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a pediatric or specialty pharmaceutical requirement fulfilled through AmerisourceBergen's established federal contract infrastructure. The award was made without a set-aside designation, indicating competitive procurement. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare systems globally. The IDC represents part of DLA's pharmaceutical distribution strategy, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen's delivery orders under this vehicle demonstrate its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/13/25 |